Navigation Links
MedImmune grants 5 new fellowships to help expand premature infant follow-up care research
Date:10/12/2008

BOSTON, MA, October 13, 2008 Five neonatology fellows have been awarded grants designed to stimulate interest and research in the area of follow-up care of the premature infant as part of MedImmune's Fellowship Program. The grants, which underscore MedImmune's commitment to expanding research within pediatric medicine, will provide each recipient's institution a $35,000 grant, totaling $175,000 in research funding. The five recipients were acknowledged on Sunday, October 12, 2008 at a reception coinciding with the American Academy of Pediatrics (AAP) 2008 National Conference and Exhibition.

MedImmune, a leading biotech with broad expertise in infectious disease research, has awarded funding for respiratory viral disease study during the past five years. The company expanded its program to include grants on premature infant follow-up care to help broaden research in other areas of pediatrics.

"To fully protect premature children from potentially severe pediatric infectious diseases and other health and developmental issues, we must further explore best-practices for appropriate follow-up care," said Frank J. Malinoski, M.D., Ph.D., senior vice president, medical and scientific affairs. "MedImmune is honored to support the five fellows with the continuation of this important research to ensure more is being done to address the specialized health needs of premature infants."

The five fellowship recipients were selected by independent reviewers consisting of external pediatric physicians from across the United States. All candidates were required to be full-time fellows in an American Board of Pediatrics-accredited fellowship program and be conducting original research as their primary focus.

The Fellowship Program grant recipients are:

  • Jennifer Benjamin, M.D.
    Neonatology Fellow, Duke University
    Project Title: Utility of Pre-Discharge Cerebral Oximetry in Premature Infants With and Without Residual Lung Disease - Impact on Growth, Health, and Development In the First Year of Life

  • Malgorzata Bulanowski, M.D.
    Neonatology Fellow, Rochester University
    Project Title: Reach Out and Read. The Outcome of NICU and Neonatal Clinic- Based Intervention on Language Development in Preterm Born Children

  • Amy Fowler, M.D.
    Neonatology Fellow, University of Texas at San Antonio
    Project Title: Genetic and Environmental Influences on Growth, Motor, Cognitive, Behavioral and Language Development of Premature Infants

  • Elizabeth Rogers, M.D.
    Neonatology Fellow, University of California San Francisco
    Project Title: Defining The "New" Prematurity: Neurodevelopmental Outcomes of Preterm Infants Conceived by Assisted Reproductive Technologies.

  • Charles Sauer, D.O.
    Neonatal-Perinatal Medicine Fellow, University of California San Diego
    Project Title: Improving Longitudinal Growth in Preterm Infants with Individualized Fortification of Breast Milk with Near Infrared Spectroscopy

In addition to the 2008 Fellowship Program, MedImmune has invested an additional $550,000 this year in educational and charitable grants to various AAP chapters in support of pediatric health and the AAP's Preemie Health Coalition. The Preemie Health Coalition is a consortium of more than 25 national organizations that have assembled under the AAP to marshal their resources and experience on behalf of premature infants who cannot advocate for themselves.


'/>"/>

Contact: Tor Constantino
301-398-5801
Edelman Public Relations
Source:Eurekalert

Related medicine news :

1. MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech
2. MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
3. MedImmune Expands Scientific and Engineering Leadership
4. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
5. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
6. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
7. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
8. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
9. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
10. Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimers Patents and Patent Applications
11. Ohio Dental Association Foundation Again Awards Over $60,000 in Dental Education Grants and Scholarships Across Ohio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... San Francisco, California (PRWEB) , ... May 23, 2017 , ... ... released results of its new survey in an infographic on the current state of ... 900 U.S. respondents, familiar with anxiety, was conducted in April 2017 and benchmarked general ...
(Date:5/22/2017)... ... 2017 , ... The American Academy of Thermology ... and clinical application of medical infrared imaging, has announced two new educational offerings ... services. , The first new educational offering is an online self-directed Physician Member ...
(Date:5/22/2017)... NC (PRWEB) , ... May 22, 2017 , ... ... Matthews Periodontics, is now welcoming new patients with periodontal plastic surgery treatments, including ... from a general dentist. Dr. Green provides these esthetic and functional procedures to ...
(Date:5/22/2017)... ... ... An inventor from Columbia, S.C., wants to offer people with manual disabilities a ... firework accident, so she couldn’t grip a pen properly," he said. "This inspired me ... created a prototype for the HELPEN HAND, a special pen that enables a person ...
(Date:5/22/2017)... ... May 22, 2017 , ... Galena, Alaska, has a population of less than ... when it was targeted to build a nuclear plant by the TOSHIBA Corporation. , ... Marvin L. Yoder describes the journey to get power to his small town, off ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... May 15, 2017 Enterin Inc., a privately-held CNS ... developing novel compounds to treat Parkinson,s disease (PD), has enrolled ... a Phase 1/2a randomized, controlled, multicenter study involving patients with ... enroll 50 patients over a 9-to-12-month period. The first stage ... patients with PD. Participating sites include Denver ...
(Date:5/11/2017)... , May 11, 2017  Thornhill Research ... has been awarded an $8,049,024 USD five-year, firm-fixed-priced, ... through the Canadian Commercial Corporation (CCC) ( ... Anesthesia Systems to administer general anesthesia to patients ... "The US Marine Corps have been ...
Breaking Medicine Technology: